rs587783634

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BS2BA1BP3

This summary comes from the ClinGen Evidence Repository: The allele frequency of the c.209_235del variant in FOXG1 is 0.17% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions BA1). The p.Gln70_Pro78del variant is observed in at least 2 unaffected individuals (GeneDx internal database) (BS2). The p.Gln70_Pro78del variant is an in-frame deletion present in a repetitive region of FOXG1 (BP3). In summary, the p.Gln70_Pro78del variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BS2, BP3). LINK:https://erepo.genome.network/evrepo/ui/classification/CA172179/MONDO:0100040/033

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 0 hom. )

Consequence

FOXG1
NM_005249.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign reviewed by expert panel U:1B:5

Conservation

PhyloP100: 2.38

Publications

1 publications found
Variant links:
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
LINC01551 (HGNC:19828): (long intergenic non-protein coding RNA 1551)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXG1NM_005249.5 linkc.209_235delAGCAGCAGCAGCCGCCGCCGCCGCCGC p.Gln70_Pro78del disruptive_inframe_deletion Exon 1 of 1 ENST00000313071.7 NP_005240.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXG1ENST00000313071.7 linkc.209_235delAGCAGCAGCAGCCGCCGCCGCCGCCGC p.Gln70_Pro78del disruptive_inframe_deletion Exon 1 of 1 6 NM_005249.5 ENSP00000339004.3
FOXG1ENST00000706482.1 linkc.209_235delAGCAGCAGCAGCCGCCGCCGCCGCCGC p.Gln70_Pro78del disruptive_inframe_deletion Exon 2 of 2 ENSP00000516406.1
LINC01551ENST00000675861.1 linkn.374+1475_374+1501delAGCAGCAGCAGCCGCCGCCGCCGCCGC intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.000163
AC:
21
AN:
128906
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000576
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000758
Gnomad ASJ
AF:
0.00130
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000143
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000200
Gnomad OTH
AF:
0.000565
GnomAD2 exomes
AF:
0.000257
AC:
19
AN:
73900
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000299
Gnomad ASJ exome
AF:
0.00157
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000109
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000132
AC:
127
AN:
962086
Hom.:
0
AF XY:
0.000135
AC XY:
63
AN XY:
467330
show subpopulations
African (AFR)
AF:
0.000256
AC:
5
AN:
19562
American (AMR)
AF:
0.000213
AC:
4
AN:
18808
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
19
AN:
13408
East Asian (EAS)
AF:
0.00
AC:
0
AN:
13832
South Asian (SAS)
AF:
0.0000522
AC:
2
AN:
38326
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
17056
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2352
European-Non Finnish (NFE)
AF:
0.000118
AC:
95
AN:
804284
Other (OTH)
AF:
0.0000580
AC:
2
AN:
34458
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000163
AC:
21
AN:
128988
Hom.:
0
Cov.:
31
AF XY:
0.0000955
AC XY:
6
AN XY:
62816
show subpopulations
African (AFR)
AF:
0.0000574
AC:
2
AN:
34822
American (AMR)
AF:
0.0000757
AC:
1
AN:
13208
Ashkenazi Jewish (ASJ)
AF:
0.00130
AC:
4
AN:
3086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4266
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3954
European-Finnish (FIN)
AF:
0.000143
AC:
1
AN:
6996
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
180
European-Non Finnish (NFE)
AF:
0.000200
AC:
12
AN:
59870
Other (OTH)
AF:
0.000559
AC:
1
AN:
1788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000612
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:5
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Rett syndrome, congenital variant Uncertain:1Benign:1
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 06, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Jun 21, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Mar 17, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

FOXG1 disorder Benign:1
Apr 14, 2023
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The allele frequency of the c.209_235del variant in FOXG1 is 0.17% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions BA1). The p.Gln70_Pro78del variant is observed in at least 2 unaffected individuals (GeneDx internal database) (BS2). The p.Gln70_Pro78del variant is an in-frame deletion present in a repetitive region of FOXG1 (BP3). In summary, the p.Gln70_Pro78del variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BS2, BP3).

not provided Benign:1
Feb 05, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.4
Mutation Taster
=153/47
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587783634; hg19: chr14-29236677; API